June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Dietary omega-3 and omega-6 fatty acid intake and ocular surface disease in postmenopausal women
Author Affiliations & Notes
  • Jillian F Meadows
    The School of Optometry, The University of Alabama at Birmingham, Birmingham, AL
  • Lynn R Wolters
    The Ohio State University, Columbus, OH
  • Lisa A Jones-Jordan
    The Ohio State University, Columbus, OH
  • Jason J Nichols
    The School of Optometry, The University of Alabama at Birmingham, Birmingham, AL
  • Kelly K Nichols
    The School of Optometry, The University of Alabama at Birmingham, Birmingham, AL
  • Footnotes
    Commercial Relationships Jillian Meadows, None; Lynn Wolters, None; Lisa Jones-Jordan, None; Jason Nichols, None; Kelly Nichols, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 314. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Jillian F Meadows, Lynn R Wolters, Lisa A Jones-Jordan, Jason J Nichols, Kelly K Nichols; Dietary omega-3 and omega-6 fatty acid intake and ocular surface disease in postmenopausal women. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):314.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: The incidence of self-reported dry eye disease (DED) has been linked to low omega-3 fatty acid consumption and high omega-6:omega-3 fatty acid ratios. Meibomian gland dysfunction (MGD) and its association with omega fatty acid intake, however, is currently unknown. A cross-sectional, clinical study on postmenopausal women was conducted to evaluate the relationship between omega fatty acid consumption and clinically confirmed cases of both DED and MGD.

Methods: Four hundred thirty-nine postmenopausal women (≥ 50 years of age) whose last menstrual periods were twelve months prior to enrollment were examined. All subjects answered research-validated dry eye questions, underwent a comprehensive ocular surface evaluation, and completed the Vio Food Frequency Questionnaire (Princeton, NJ) to estimate their dietary intake of omega-3 (n-3) and omega-6 (n-6) fatty acids. Subjects were categorized into two binary classifications based upon (1) whether they were symptomatic for dry eye (DED vs non-DED) and (2) whether they had clinically confirmed MGD as determined by the MGD Workshop diagnostic algorithm (MGD vs non-MGD). Mean intake of dietary fatty acids were compared between groups with two-sample t-tests. Logistic regression models were used to estimate the odds ratios and 95% CIs associated with n-3 intake, n-6 intake, and n-6:n-3 ratio.

Results: For DED vs non-DED, there were no statistically significant differences in mean n-3 intake (1.95 ± 1.31 g vs 1.87 ± 1.25, p=0.54), n-6 intake (15.28 ± 9.24 g vs 15.32 ± 11.55, p=0.97), and n-6:n-3 ratio (8.27 ± 2.67 vs 8.36 ± 2.81, p=0.71). For MGD vs non-MGD, there were no statistically significant differences in mean n-3 intake (1.97 ± 1.15 vs 1.90 ± 1.30, p=0.63), n-6 intake (15.27 ± 9.47 vs 15.31 ± 10.69, p=0.98), and n-6:n-3 ratio (7.93 ± 2.21 vs 8.39 ± 2.82, p=0.12). Logistic regression models were used to adjust for age, race, BMI, total fat intake, presence or absence of an eye exam within 12 months, and presence or absence of other comorbidities. The odds ratios and 95% CIs for DED and MGD did not differ significantly from 1.00 among any of the quintiles for n-3 intake, n-6 intake, or n-6:n-3 ratio.

Conclusions: Self-reported dietary consumption of omega-3 and omega-6 fatty acids conferred no increased or decreased association of clinically confirmed dry eye disease or meibomian gland dysfunction in this large sample of postmenopausal women.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×